Background: Evidence indicates that Dickkopf-1 (DKK-1) levels may be a biomarker for cancer risk. Theaim of this study was to assess DKK-1 and its correlation with clinic-pathological features in patients withbladder cancer. Materials and Methods: DKK-1 levels were determined in serum samples from 90 patients withbladder cancer before transurethral tumor resection. The concentrations of DKK-1 were determined by usingenzyme linked immune-sorbent assay (ELISA). Results: Elevated preoperative DKK-1 levels were associatedwith tumor stage (p<0.001), grade (p<0.001) and histological grade (p<0.001). Conclusions: The results of ourstudy demonstrated that the level of serum DKK-1 is correlated with both disease progression and increase inthe tumor grade. Preoperative serum DKK-1 elevation may thus represent a novel marker for the determinationof bladder cancer and the detection of patients with a likely poor clinical outcome.
(2014). Dickkopf-1 Levels in Turkish Patients with Bladder Cancer and its Association with Clinicopathological Features. Asian Pacific Journal of Cancer Prevention, 15(1), 381-384.
MLA
. "Dickkopf-1 Levels in Turkish Patients with Bladder Cancer and its Association with Clinicopathological Features". Asian Pacific Journal of Cancer Prevention, 15, 1, 2014, 381-384.
HARVARD
(2014). 'Dickkopf-1 Levels in Turkish Patients with Bladder Cancer and its Association with Clinicopathological Features', Asian Pacific Journal of Cancer Prevention, 15(1), pp. 381-384.
VANCOUVER
Dickkopf-1 Levels in Turkish Patients with Bladder Cancer and its Association with Clinicopathological Features. Asian Pacific Journal of Cancer Prevention, 2014; 15(1): 381-384.